EM SAQs · Acute ischaemic stroke
Hyperacute management of acute ischaemic stroke
An ACEM-style SAQ on the hyperacute ischaemic stroke pathway: recognition, CT/CTA, alteplase dosing, BP thresholds, and thrombectomy activation for large-vessel occlusion.
On this page
Study tools
Target exams
Model answer
Reveal model answerShowHide
Thrombolysis. She is within 4.5 hours of a witnessed last-known-well time with no haemorrhage on CT. Tenecteplase 0.25 mg/kg (maximum 25 mg) or alteplase 0.9 mg/kg is recommended, started as quickly as possible without waiting for further multimodal imaging; alteplase is given over 60 minutes with 10 per cent as a 1-minute bolus.[6]
Blood pressure. Her BP of 178/98 is below the 185/110 level used before reperfusion in major thrombectomy trials; after thrombolysis SBP is maintained between 140 and 180 mm Hg.[6]
Thrombectomy. A right M1 occlusion within 6 hours with NIHSS of 6 or more, prestroke mRS 0 to 1 and ASPECTS 3 to 10 meets the recommendation for endovascular thrombectomy.[6]
The evidence. ECASS III showed benefit from alteplase between 3 and 4.5 hours, and AcT compared tenecteplase 0.25 mg/kg with alteplase 0.9 mg/kg within 4.5 hours.[2][10]
Complications to anticipate. Symptomatic intracranial haemorrhage occurred in 3.3 per cent of rtPA-treated patients in one series, with in-hospital mortality of 52.3 per cent; orolingual angioedema occurred in 0.4 per cent in another and can need intubation.[11][9]
References11ShowHide
- [1]National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine, 1995.PMID 7477192
- [2]Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke (ECASS III). New England Journal of Medicine, 2008.PMID 18815396
- [3]Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke (MR CLEAN). New England Journal of Medicine, 2015.PMID 25517348
- [4]Thomalla G, et al. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset. New England Journal of Medicine, 2018.PMID 29766770
- [5]Ma H, et al. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke. New England Journal of Medicine, 2019.PMID 31067369
- [6]Prabhakaran S, Gonzalez NR, Zachrison KS, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke, 2026.PMID 41582814
- [7]Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct (DAWN). New England Journal of Medicine, 2018.PMID 29129157
- [8]Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging (DEFUSE 3). New England Journal of Medicine, 2018.PMID 29364767
- [9]Censori B, Partziguian T, Bonito V, et al. Incidence of orolingual angioedema after intravenous thrombolysis for stroke. Neurol Sci, 2018.PMID 30084073
- [10]Menon BK, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT). Lancet, 2022.PMID 35779553
- [11]Yaghi S, et al. Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective Study. JAMA Neurol, 2015.PMID 26501741